KemPharm stock: buy or sell?

KMPH stock price: $0.42 5.00% At close on January 17th, 2020

Updated on:
January 17th, 2020

0

After sliding for 4 sessions, Friday KemPharm rocketed an extraordinary 5.00%, closing at $0.42. On January 16th KMPH plummed a frightening -20.00%. On Jan/10 KMPH rocketed an amazing 10.67%. Friday session broke a read streak of 4 days.

KemPharm, Inc., a clinical-stage specialty pharmaceutical company, discovers and develops new proprietary prodrugs in the United States.

Should I buy KemPharm stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, KemPharm stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is KemPharm stock a buy?

Banks and financial institutions post stock ratings everyday. At Stocks2.com, we collected 4 ratings published for KMPH stock in the last month.

The general sentiment of these ratings is bullish for KMPH stock, with 3 positive ratings.
Is KMPH a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-5Roth CapitalBuyNeutral
2019-9-5HC Wainwrightn/aBuy
2019-6-19HC Wainwrightn/aBuy
2019-5-23Oppenheimern/aOutperform

KemPharm stock analysis

Daily outlook

After sliding a frightening -20.00% on Jan/16, KemPharm closed yesterday at $0.42 and rocketed an extraordinary 5.00%.

After sliding for 4 days, Friday KemPharm rocketed an extraordinary 5.00%, closing at $0.42.

KMPH stock chart (daily)

Weekly outlook

After boosting a super good 45.33% in a week last week, KemPharm closed this week at $0.42 and plunged a dreadful -44.00%.

KMPH stock chart (weekly)

KemPharm stock price history

KemPharm IPO was on April 16th, 2015 at $11.75 per share1. Since then, KMPH stock lost a -96.40%, with a yearly average of -24.10%.

1: Adjusted price after possible price splits or reverse-splits.

KemPharm stock historical price chart

KMPH stock reached 52-week highs at $2.85, and all-time highs 2015-08-14 with a price of 26.15.

KemPharm stock price target is $2.50

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We detected 4 price forecasts for KMPH stock posted in the last month:
KMPH stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-5Roth CapitalDowngrades$4.25$1.05-75.3%
2019-9-5HC WainwrightReiteratesn/a$3.00-
2019-6-19HC WainwrightInitiatesn/a$3.00-
2019-5-23OppenheimerLowers Target$8.00$3.00-62.5%
(in average)$6.10$2.50-59.0%
Moving in a range from $3.00 and $1.05, the price prediction for KMPH stock is $2.50. In average, analysts' outlook on KMPH price forecast is negative, downgrading the prediction by a -59.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

KemPharm failed experts on February when it published an Earnings per Share (EPS) of $-0.20 when the market consensus was $-0.48.
KMPH earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-1.11n/a
2017-Q2-n/a-0.44n/a
2017-Q32017-11-09-0.67-0.68n/a
2017-Q42018-03-29-0.71-0.72n/a
2018-Q12018-05-10-0.7-1.11n/a
2018-Q22018-08-09-0.98-0.91n/a
2018-Q32018-11-08-0.74-0.94n/a
2018-Q42019-02-28-0.48-0.2n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In , KemPharm annual revenues to M dollars from marked in . , its income margin (compared to sales) to , that is million.

KMPH annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter earnings marked $-5.18 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, KemPharm sales marked a neutral movement and stayed stable a nan%. Looking back to recent quarterly results, KemPharm posted 7 negative quarters in a row.
KMPH quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

KemPharm ownership

When you are planning to buy a stock, it's always worth to check its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For KemPharm, 12.29% of all outstanding shares are owned by its staff.

In case of KemPharm stock, 23.99% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for KMPH stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related companies:

KMPH
Market cap$15.3 M
Total shares36.3 M
Float shares24.5 M
  - Institutional holdings (%)24.0%
  - Insider holdings (%)12.3%
Shares in short selling0.0%

KemPharm summary

Friday, January 17th, 2020
Open$0.41
Close$0.42
Day range$0.40 - $0.44
Previous close$0.40
Session gain5.00%
Average true range$0.11
50d mov avg$0.45
100d mov avg$0.58
200d mov avg$1.02
Daily pattern
Weekly pattern lt03a

KemPharm performance

To measure stock performance is always good to compare with competitors or related stocks. In the following table, we compare KemPharm performance to :
Stock3m6m12m
KMPHKemPharm-28.81%-71.43%-84.09%

KemPharm competitors

Unfortunately, we could not find any public company that could be defined as KemPharm competitor. This doesn't mean KemPharm does not have any competitor in the market, it's just we could not detected it.